A randomised, placebo-controlled, double blind, crossover trial on the effect of a 20:1 cannabidiol: Δ9-tetrahydrocannabinol medical cannabis product on neurocognition, attention, and mood
Article in European Neuropsychopharmacology (March 2024)
The most recent citing publications are shown below. View all 99 publications that cite this research output on Dimensions.
Article in European Neuropsychopharmacology (March 2024)
Article in Journal of Cannabis Research (February 2024)
Article in eLife (December 2023)